The Minara Chamber of Commerce, South Africa, recently hosted a webinar on the use of Ivermectin in the treatment of Covid-19. The webinar was attended by over 450 doctors, researchers, academics and public and private sector representatives.
Dr Pierre Kory responded to the South African National Department of Health’s “rapid review” and presented meta-analysis research conducted by Dr Andrew Hill on behalf of the WHO.
“We’re not here promoting Ivermectin based on no data. This is the opposite of hydroxychloroquine. We actually started to see this mountain of data coming at us and we said there is something real here, so we’re acting on it,” said Dr Kory.
“We’re almost mandated based on the existing evidence of a safe, cheap and widely available drug, given that the likelihood that it’s life-saving, faster recovery and that it limits transmission. In a pandemic, on a risk calculation at this moment, I really think we have to strongly consider putting it into use. The alternatives are terrible. Some of these health care systems are starting to collapse, our hospitals are filling and here you have a realistic and scientifically valid solution, and I really think it should be pursued.”
Panellists included Yunus Parak, Prof Colleen Aldous, Dr Martin Gill, Dr Yakub Essack, Solly Suleman, and Dr Essa.
00:00 Introduction to Ivermectin
05:30 Response to SA DOH Rapid Review
09:50 Review of Meta-analysis of clinical trials of ivermectin to treat Covid-19 infection
24:19 Comments and questions from the panel